1-7 of 7
Shinsuke Kido
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

GM-CSF and IL-4 induce dendritic cell differentiation and disrupt osteoclastogenesis through M-CSF receptor shedding by up-regulation of TNF-α converting enzyme (TACE)

Masahiro Hiasa, Masahiro Abe, Ayako Nakano, Asuka Oda, Hiroe Amou, Shinsuke Kido, Kyoko Takeuchi, Kumiko Kagawa, Kenichiro Yata, Toshihiro Hashimoto, Shuji Ozaki, Kenzo Asaoka, Eiji Tanaka, Keiji Moriyama, Toshio Matsumoto
Journal: Blood
Blood (2009) 114 (20): 4517–4526.
https://doi.org/10.1182/blood-2009-04-215020
Published: 2009
Includes: Supplemental data
Journal Articles

SB431542, a TGF-Beta Receptor Kinase Inhibitor, Restores Bone Formation Which Ameliorates Myeloma-Induced Microenvironment.

Kyoko Takeuchi, MD, Masahiro Abe, MD, Asuka Oda, MT, Hiroe Amou, MT, Masahiro Hiasa, DDS, Jin Asano, MD, Kenichi Kitazoe, MD, Toshihiro Hashimoto, MD, Shuji Ozaki, MD, Shinsuke Kido, PhD, Daisuke Inoue, MD, Toshio Matsumoto, MD
Journal: Blood
Blood (2006) 108 (11): 3479.
https://doi.org/10.1182/blood.V108.11.3479.3479
Published: 2006
Journal Articles

Angiogenesis and Osteoclastogenesis Are Mutually Stimulated in Myeloma: A Role for VEGF and Osteopontin.

Yoichi Tanaka, Masahiro Abe, Masahiro Hiasa, Toshihiro Hashimoto, Shinsuke Kido, Daisuke Inoue, Shuji Ozaki, Keiji Moriyama, Toshio Matsumoto
Journal: Blood
Blood (2005) 106 (11): 2500.
https://doi.org/10.1182/blood.V106.11.2500.2500
Published: 2005
Journal Articles

Myeloma cells suppress bone formation by secreting a soluble Wnt inhibitor, sFRP-2

Takashi Oshima, Masahiro Abe, Jin Asano, Tomoko Hara, Kenichi Kitazoe, Etsuko Sekimoto, Yoichi Tanaka, Hironobu Shibata, Toshihiro Hashimoto, Shuji Ozaki, Shinsuke Kido, Daisuke Inoue, Toshio Matsumoto
Journal: Blood
Blood (2005) 106 (9): 3160–3165.
https://doi.org/10.1182/blood-2004-12-4940
Published: 2005
Journal Articles

Myeloma Cells Suppress Osteoblast Differentiation by Secreting a Soluble Wnt Inhibitor, sFRP-2.

Takashi Oshima, MD, Masahiro Abe, MD, Jin Asano, MD, Tomoko Hara, MD, Kenichi Kitazoe, MD, Etsuko Sekimoto, MD, Yoichi Tanaka, MD, Hironobu Shibata, MD, Toshihiro Hashimoto, MD, Shuji Ozaki, MD, Shinsuke Kido, MD, Daisuke Inoue, MD, Toshio Matsumoto, MD
Journal: Blood
Blood (2004) 104 (11): 2356.
https://doi.org/10.1182/blood.V104.11.2356.2356
Published: 2004
Journal Articles

Osteoclasts enhance myeloma cell growth and survival via cell-cell contact: a vicious cycle between bone destruction and myeloma expansion

Masahiro Abe, Kenji Hiura, Javier Wilde, Atsushi Shioyasono, Keiji Moriyama, Toshihiro Hashimoto, Shinsuke Kido, Takashi Oshima, Hironobu Shibata, Shuji Ozaki, Daisuke Inoue, Toshio Matsumoto
Journal: Blood
Blood (2004) 104 (8): 2484–2491.
https://doi.org/10.1182/blood-2003-11-3839
Published: 2004
Journal Articles

Role for macrophage inflammatory protein (MIP)-1α and MIP-1β in the development of osteolytic lesions in multiple myeloma

Masahiro Abe, Kenji Hiura, Javier Wilde, Keiji Moriyama, Toshihiro Hashimoto, Shuji Ozaki, Shingo Wakatsuki, Masaaki Kosaka, Shinsuke Kido, Daisuke Inoue, Toshio Matsumoto
Journal: Blood
Blood (2002) 100 (6): 2195–2202.
https://doi.org/10.1182/blood.V100.6.2195
Published: 2002